A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin detemir
Ertugliflozin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Ertugliflozin.
Insulin detemir
Lixisenatide
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Lixisenatide.
Insulin detemir
Alogliptin
The risk or severity of hypoglycemia can be increased when Alogliptin is combined with Levomilnacipran.
Insulin detemir
Liraglutide
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Levomilnacipran.
Insulin detemir
Insulin glulisine
The risk or severity of hypoglycemia can be increased when Insulin glulisine is combined with Levomilnacipran.
Insulin detemir
Insulin detemir
The risk or severity of hypoglycemia can be increased when Insulin detemir is combined with Levomilnacipran.
Insulin detemir
Gastric inhibitory polypeptide
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Gastric inhibitory polypeptide.
Insulin detemir
Tirzepatide
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Tirzepatide.
Insulin detemir
Englitazone
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Englitazone.
Insulin detemir
Taspoglutide
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Taspoglutide.
Insulin detemir
Semaglutide
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Semaglutide.
Insulin detemir
Metahexamide
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Metahexamide.
Insulin detemir
Guar gum
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Guar gum.
Insulin detemir
Carbutamide
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Carbutamide.
Insulin detemir
Remogliflozin etabonate
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Remogliflozin etabonate.
Insulin detemir
Sotagliflozin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Sotagliflozin.
Insulin detemir
Evogliptin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Evogliptin.
Insulin detemir
Anagliptin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Anagliptin.
Insulin detemir
Gemigliptin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Gemigliptin.
Insulin detemir
Carmegliptin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Carmegliptin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3